Publication|Articles|March 19, 2026
- Pharmaceutical Executive: March 2026
- Volume 46
- Issue 2
Pharmaceutical Executive: March 2026 Interactive Digital Edition
View the Pharmaceutical Executive March 2026 issue in an interactive format.
Advertisement
Click
Articles in this issue
2 months ago
Data and Trust2 months ago
Andrew Hall: The Discipline of Conviction2 months ago
Cautious Momentum: Biopharma Review and Outlook2 months ago
Orphan Product Risk ContractingAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5
